By John Q. Hosedrinker 
Even as it grappled with the deadliest drug epidemic in American history, the U.S. Drug Enforcement Administration permitted hundreds of thousands of fentanyl pills to reach the streets of New Mexico between 2023 and 2025. DEA agents repeatedly monitored shipments of these pills without seizing them, a tactic employed to build larger criminal cases against traffickers of the synthetic opioid. This strategy, however, raised concerns among agents and experts, who argued it amounted to a gamble with public safety and potentially violated Justice Department guidelines. While the DEA maintains its investigative decisions were lawful and reasonable, critics assert that this approach put communities at risk and may have contributed to overdose deaths.
Read the original article here
It’s truly disheartening to learn about the staggering amounts of fentanyl making their way onto our streets, especially when records suggest the DEA was aware and, for reasons that remain unclear, took no apparent action. This isn’t a partisan issue; the reports span across administrations from 2023 to 2025, indicating a persistent problem that transcends political cycles. It brings to mind past “wars on drugs” that, while perhaps well-intentioned in their rhetoric, seem to have yielded little more than continued destruction and loss of life.
The notion that law enforcement might intentionally allow a problem to escalate before intervening feels like a cynical interpretation, yet the evidence, as suggested, points to a disturbing pattern. It’s as if the problem itself must be manufactured or allowed to fester to justify the existence and expansion of certain agencies, complete with their “private lawless militias” and declared states of emergency. Public safety, in such scenarios, appears to take a backseat to the potential for dramatic photo opportunities and the ongoing need to prove relevance and secure funding.
There’s a palpable frustration when comparing the DEA’s approach to fentanyl with the stringent regulations surrounding medications like ADHD treatments. Many individuals rely on these medications to function in daily life, and the constant struggle to obtain timely refills, often facing shortages or strict prescription limits, feels like an unnecessary hardship. It’s a stark contrast to the apparent laxity in curbing the influx of a substance that is devastating communities.
One can’t help but wonder about the strategic decisions behind allowing large quantities of drugs to enter the country. Is it truly about “hooking a bigger fish,” as some suggest, or is there a more complex, perhaps even morally compromised, calculus at play? The idea that agencies might need to “make their profit back before making arrests” paints a grim picture, implying a system that benefits from the very problem it’s meant to solve. This kind of approach fuels narratives that certain political groups are doing nothing, when the reality seems far more intertwined and complicated.
The sheer volume of fentanyl entering the country is not just a statistical concern; it represents countless lives irrevocably altered or tragically cut short. Families are left to grapple with unimaginable grief, while communities are burdened by the devastating consequences of addiction and overdose. The fact that this situation has been allowed to reach such alarming proportions, with seemingly little effective intervention from those tasked with protecting public health and safety, is profoundly disturbing.
It’s also worth considering the broader implications of these drug trafficking issues. The historical parallels are unnerving, from the crack epidemic of the 80s to the current fentanyl crisis. Each instance seems to highlight a recurring theme of unintended consequences, systemic failures, and perhaps even deliberate inaction. The militarization of law enforcement, accelerated during periods like the War on Drugs, raises questions about whether the tools and tactics employed are truly addressing the root causes of addiction and trafficking, or merely perpetuating a cycle of control and punishment.
The effectiveness of current strategies is certainly up for debate. When juxtaposed with the difficulties in accessing essential medications, the focus and resources allocated seem disproportionate. This raises critical questions about priorities and the fundamental purpose of these agencies. Is the goal truly to eradicate the problem, or to manage it in a way that preserves the agencies themselves and their operational mandates?
Ultimately, the information suggesting that staggering amounts of fentanyl have hit the streets while the DEA watched and took no action demands serious scrutiny. It points to a systemic failure that has devastating human costs. Understanding the motivations and mechanisms behind these decisions, whether they stem from strategic miscalculations, bureaucratic inertia, or something far more sinister, is crucial in charting a path toward genuine solutions and preventing future tragedies. The conversation needs to move beyond blame and towards a comprehensive re-evaluation of our drug policies and enforcement strategies.